Term
Risk Factors for Ovarian Cancer |
|
Definition
- Family history
- Nulliparity
- First child after age 35
- Advanced age
- North American or Northern European descent
- Prolonged use of ovulation-inducing drugs
|
|
|
Term
Negative Risk Factors for Ovarian Cancer |
|
Definition
- First child before age 25
- Oral contraceptive use
- At least two full term pregnancies
- Breast feeding
- Tubal ligation?
|
|
|
Term
Presentation of Ovarian Cancer |
|
Definition
- Most patients present with advanced disease (Stage III or IV)
- Nonspecific symptoms
Nausea
Dyspepsia
Flatulence
Bloating
Early satiety
Abnormal vaginal bleeding
Abdominal distention and discomfort
Ascites
Amenorrhea
Abdominal/pelvic masses |
|
|
Term
Poor prognostic indicators for Ovarian Cancer |
|
Definition
- Stage
- Histological grade (III)
- Presence of ascites at diagnosis
- Tumor on ovary surface
- Age > 65
- Volume of residual disease after surgery
- High post-op CA-125
|
|
|
Term
Which patients get surgery in Ovarian Cancer? |
|
Definition
Everyone!
- If need to preserve fertility and only one ovary involved, can spare the unaffected ovary
- Otherwise all patients get total abdominal hysterectomy/bilateral salpingo oopherectomy
|
|
|
Term
General Principles of Ovarian Cancer Treatment: Stage I |
|
Definition
Surgery then observation (rarely)
OR
Surgery then Chemo with Carboplatin/paclitaxel |
|
|
Term
Carboplatin/Paclitaxel: ADRs |
|
Definition
Quick
Hypersensitivity
Short Term
- NV
- Myelosuppression
- Mucositis
- Alopecia
- Neuropathies
- Nephrotoxicity
Long Term
Hepatoxicity |
|
|
Term
General Principles of Ovarian Cancer Treatment: Stage II |
|
Definition
|
|
Term
General Principles of Ovarian Cancer Treatment: Stage III |
|
Definition
Surgery then Intraperitoneal Chemo
- IV palitaxel then
- IP Cisplatin and IP Paclitaxel
|
|
|
Term
IP Chemo with Carboplatin/Paclitaxel: ADRs |
|
Definition
Quick
Hypersensitivity
Short Term
- PAIN
- FATIGUE
- NV
- Myelosuppression
- Neuropathies
- Mucositis
Long Term
Hepatotoxicity |
|
|
Term
Monitoring Ovarian Cancer Chemotherapy |
|
Definition
- Pts should be seen every 2-4 months for first 2 yrs then every 6 months for 3 yrs
- Check CA-125 if elevated at presentation
- Physical exam including pelvic
- Abdominal CT
- Chest X-ray
|
|
|
Term
Ovarian Cancer Relapse: Platinum sensitive |
|
Definition
Relapse > 6 months
If platinum sensitive, repeat initial chemotherapy |
|
|
Term
Ovarian Cancer Relapse: Platinum resistant |
|
Definition
|
|
Term
Salvage agents for Platinum Resistant Chemo Relapse |
|
Definition
- Topotecan
- Liposomal doxorubicin
- PO Etoposide
- Altretamine
- Gemcitabine
|
|
|